Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy

被引:26
作者
Rutihinda, Cleopatra [1 ]
Haroun, Ryma [1 ]
Saidi, Nour Elhouda [1 ]
Ordonez, Juan Pablo [1 ]
Naasri, Sahar [1 ]
Levesque, Dominique [2 ]
Boisvert, Francois-Michel [2 ]
Fortier, Pierre-Hugues [3 ]
Belzile, Mathieu [3 ]
Fradet, Laurent [3 ]
Hubert-Tremblay, Vincent [1 ]
Turgeon, Guy Anne [1 ]
Wang, Chang Shu [1 ]
Delage, Patrick [1 ]
Rousseau, Etienne [1 ]
Paquette, Benoit [1 ]
Oweida, Ayman J. [1 ]
机构
[1] Univ Sherbrooke, Fac Med & Sci La Sante, Dept Nucl Med & Radiobiol, Sherbrooke, PQ, Canada
[2] Univ Sherbrooke, Fac Med & Sci La Sante, Dept Immunol & Cell Biol, Sherbrooke, PQ, Canada
[3] Univ Sherbrooke, Fac Med & Sci La Sante, Dept Surg, Sherbrooke, PQ, Canada
关键词
Head and neck squamous cell carcinomas; Radiotherapy; Radioresistance; Regulatory T cells; CCR6-CCL20; axis; TUMOR; CANCER; RADIOTHERAPY; EXPRESSION; LYMPHOCYTES; MICROENVIRONMENT; OROPHARYNX; CHEMOKINES; RESISTANCE; PEPTIDE;
D O I
10.1007/s00262-022-03313-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Radioresistance of HNSCCs remains a major challenge for effective tumor control. Combined radiotherapy (RT) and immunotherapy (IT) treatment improved survival for a subset of patients with inflamed tumors or tumors susceptible to RT-induced inflammation. To overcome radioresistance and improve treatment outcomes, an understanding of factors that suppress anti-tumor immunity is necessary. In this regard, regulatory T cells (Tregs) are critical mediators of immune suppression in HNSCCs. In this study, we investigated how radiation modulates Treg infiltration in tumors through the chemokine CCL20. We hypothesized that radiation induces CCL20 secretion resulting in Treg infiltration and suppression of anti-tumor immunity. Methods Human and mouse HNSCC cell lines with different immune phenotypes were irradiated at doses of 2 or 10 Gy. Conditioned media, RNA and protein were collected for assessment of CCL20. qPCR was used to determine CCL20 gene expression. In vivo, MOC2 cells were implanted into the buccal cavity of mice and the effect of neutralizing CCL20 antibody was determined alone and in combination with RT. Blood samples were collected before and after RT for analysis of CCL20. Tumor samples were analyzed by flow cytometry to determine immune infiltrates, including CD8 T cells and Tregs. Mass-spectrometry was performed to analyze proteomic changes in the tumor microenvironment after anti-CCL20 treatment. Results Cal27 and MOC2 HNSCCs had a gene signature associated with Treg infiltration, whereas SCC9 and MOC1 tumors displayed a gene signature associated with an inflamed TME. In vitro, tumor irradiation at 10 Gy significantly induced CCL20 in Cal27 and MOC2 cells relative to control. The increase in CCL20 was associated with increased Treg migration. Neutralization of CCL20 reversed radiation-induced migration of Treg cells in vitro and decreased intratumoral Tregs in vivo. Furthermore, inhibition of CCL20 resulted in a significant decrease in tumor growth compared to control in MOC2 tumors. This effect was further enhanced after combination with RT compared to either treatment alone. Conclusion Our results suggest that radiation promotes CCL20 secretion by tumor cells which is responsible for the attraction of Tregs. Inhibition of the CCR6-CCL20 axis prevents infiltration of Tregs in tumors and suppresses tumor growth resulting in improved response to radiation.
引用
收藏
页码:1089 / 1102
页数:14
相关论文
共 50 条
[1]   Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 [J].
Ang, K. Kian ;
Zhang, Qiang ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Sherman, Eric J. ;
Weber, Randal S. ;
Galvin, James M. ;
Bonner, James A. ;
Harris, Jonathan ;
El-Naggar, Adel K. ;
Gillison, Maura L. ;
Jordan, Richard C. ;
Konski, Andre A. ;
Thorstad, Wade L. ;
Trotti, Andy ;
Beitler, Jonathan J. ;
Garden, Adam S. ;
Spanos, William J. ;
Yom, Sue S. ;
Axelrod, Rita S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2940-+
[2]   Head and neck cancer relapse after chemoradiotherapy correlates with CD163+macrophages in primary tumour and CD11b+myeloid cells in recurrences [J].
Balermpas, P. ;
Roedel, F. ;
Liberz, R. ;
Oppermann, J. ;
Wagenblast, J. ;
Ghanaati, S. ;
Harter, P. N. ;
Mittelbronn, M. ;
Weiss, C. ;
Roedel, C. ;
Fokas, E. .
BRITISH JOURNAL OF CANCER, 2014, 111 (08) :1509-1518
[3]   Biological Basis for Increased Sensitivity to Radiation Therapy in HPV-Positive Head and Neck Cancers [J].
Bol, V. ;
Gregoire, V. .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[4]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[5]   Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases [J].
Bouchard, G. ;
Bouvette, G. ;
Therriault, H. ;
Bujold, R. ;
Saucier, C. ;
Paquette, B. .
BRITISH JOURNAL OF CANCER, 2013, 109 (07) :1829-1838
[6]   The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages [J].
Boyle, Sarah T. ;
Faulkner, Jessica W. ;
McColl, Shaun R. ;
Kochetkova, Marina .
MOLECULAR CANCER, 2015, 14
[7]   Orchestrating the orchestrators: chemokines in control of T cell traffic [J].
Bromley, Shannon K. ;
Mempel, Thorsten R. ;
Luster, Andrew D. .
NATURE IMMUNOLOGY, 2008, 9 (09) :970-980
[8]   Turning Cold into Hot: Firing up the Tumor Microenvironment [J].
Duan, Qianqian ;
Zhang, Hualing ;
Zheng, Junnian ;
Zhang, Lianjun .
TRENDS IN CANCER, 2020, 6 (07) :605-618
[9]   Innate and adaptive immune cells in the tumor microenvironment [J].
Gajewski, Thomas F. ;
Schreiber, Hans ;
Fu, Yang-Xin .
NATURE IMMUNOLOGY, 2013, 14 (10) :1014-1022
[10]   Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis [J].
Galvis, Marisol Miranda ;
Borges, Gabriel Alvares ;
de Oliveira, Thiago Bueno ;
de Toledo, Isabela Porto ;
Castilho, Rogerio Moraes ;
Silva Guerra, Eliete Neves ;
Kowalski, Luiz Paulo ;
Squarize, Cristiane Helena .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 150